tiprankstipranks
Advertisement
Advertisement

GRAL Stock Latest News

Grail’s Gallery cancer detection test adopted by Priority Health
The FlyGrail’s Gallery cancer detection test adopted by Priority Health
17d ago
GRAL
Grail price target raised to $88 from $69 at TD Cowen
PremiumThe Fly
Grail price target raised to $88 from $69 at TD Cowen
18d ago
GRAL
Grail price target raised to $65 from $58 at Mizuho
PremiumThe Fly
Grail price target raised to $65 from $58 at Mizuho
18d ago
GRAL
GRAIL Shareholders Reelect Directors and Ratify Auditor
PremiumCompany Announcements
GRAIL Shareholders Reelect Directors and Ratify Auditor
1M ago
8K
GRAL
Grail Faces Federal Securities Lawsuit After NHS-Galleri Trial Falls Short and Stock Drops Over 50% 
PremiumClass Action
Grail Faces Federal Securities Lawsuit After NHS-Galleri Trial Falls Short and Stock Drops Over 50% 
2M ago
GRAL
Grail initiated with a Neutral at Goldman Sachs
PremiumThe FlyGrail initiated with a Neutral at Goldman Sachs
2M ago
GRAL
Grail assumed with a Peer Perform at Wolfe Research
Premium
The Fly
Grail assumed with a Peer Perform at Wolfe Research
2M ago
GRAL
GRAIL Names Joshua Ofman CEO, Enhances Leadership Compensation
Premium
Company Announcements
GRAIL Names Joshua Ofman CEO, Enhances Leadership Compensation
2M ago
8K
GRAL
Grail falls -15.6%
PremiumThe Fly
Grail falls -15.6%
2M ago
GRAL
Grail falls -18.4%
PremiumThe Fly
Grail falls -18.4%
2M ago
GRAL
Grail presents ‘positive’ performance, safety results from Pathfinder 2 study
PremiumThe Fly
Grail presents ‘positive’ performance, safety results from Pathfinder 2 study
2M ago
GRAL
Grail reports results from NHS-Galleri trial in presentation at ASCO meeting
PremiumThe Fly
Grail reports results from NHS-Galleri trial in presentation at ASCO meeting
2M ago
GRAL
Grail Inc. Earnings Call Highlights Growth Amid Risks
PremiumCompany AnnouncementsGrail Inc. Earnings Call Highlights Growth Amid Risks
3M ago
GRAL
Grail price target lowered to $70 from $82 at Baird
Premium
The Fly
Grail price target lowered to $70 from $82 at Baird
3M ago
GRAL
Grail price target raised to $56 from $54 at Piper Sandler
Premium
The Fly
Grail price target raised to $56 from $54 at Piper Sandler
3M ago
GRAL
Grail price target raised to $69 from $65 at TD Cowen
PremiumThe Fly
Grail price target raised to $69 from $65 at TD Cowen
3M ago
GRAL
Daniel Brennan Reiterates Buy on Strong Galleri Momentum, Clinical Catalysts, and Raises Price Target to $69
PremiumRatings
Daniel Brennan Reiterates Buy on Strong Galleri Momentum, Clinical Catalysts, and Raises Price Target to $69
3M ago
GRAL
Grail reports Q1 EPS ($2.29), consensus ($1.96)
PremiumThe Fly
Grail reports Q1 EPS ($2.29), consensus ($1.96)
3M ago
GRAL
Grail initiated with a Neutral at Mizuho
PremiumThe Fly
Grail initiated with a Neutral at Mizuho
4M ago
GRAL
Grail initiated with a Neutral at Piper Sandler
PremiumThe FlyGrail initiated with a Neutral at Piper Sandler
4M ago
GRAL
Grail announces collaboration with Epic to bring Galleri test to EHR platforms
Premium
The Fly
Grail announces collaboration with Epic to bring Galleri test to EHR platforms
4M ago
GRAL
Grail, Superpower partner to expand early cancer detection
Premium
The Fly
Grail, Superpower partner to expand early cancer detection
4M ago
GRAL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >